Lode Schuerman

gsk

H指数:41

被引数:6,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing safety in the RTS,S/AS01 malaria vaccine implementation programme: an overview and comparison of methods

评估RTS,S/AS01疟疾疫苗实施计划中的安全性：方法概述与比较

Malaria Journal

IF3

2026-04-250

PRE

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi

RTS,S/AS01E疟疾疫苗在真实世界环境下的有效性：在三剂基础免疫程序后1年的随访期内的中期分析——一项在加纳、肯尼亚和马拉维开展的4期研究

The Lancet Global Health

IF18

2025-11-060

OAAI

Latif Ndeketa; Valérie Haine; Muriel Debois; Kwaku Poku Asante; Prince Darko Agyapong; Seyram Kaali; Raghavendra Devadiga; Samuel B E Harrison; Owusu Boahen; Neil French; Kingsley Kayan; Bernhards Ogutu; Elisha Adeniji; Simon Kariuki; Seth Owusu-Agyei; Fredrick Olewe; Tikhala Makhaza Jere; Kenneth Maleta; Donnie Mategula; Phylis Mzanga; Vincent Katunga Phiri; Patrick Odum Ansah; John Orimbo; Nana Akosua Ansah; Mattea Orsini; John Michael Ong'echa; Abraham Rexford Oduro; Peter M Sifuna; Daniel K Azongo; Walter Otieno; Oscar Bangre; Michael Bandasua Kaburise; Lucy Osei Ababio; Janet Nyawira Oyieko; Valentine Sing'oei; Stellah Kevyne Amoit; Wongani Nyangulu; Lode Schuerman; Denis Awuni; Benard Omondi Ochieng; Irene Onyango; Patricia Odera-Ojwang; Esther Achieng Oguk; Yolanda Guerra Mendoza; Reuben Yego Cherop; George Odhiambo Okoth; Cristina Cravcenco; Raphael Chipatala; François Roman; Martina Oneko; Miloje Savic

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial

RTS,S/AS01E疟疾疫苗在50个月随访期间，在加纳和肯尼亚的幼儿中使用全剂量或分剂量方案时的持续有效性：一项开放标签、IIb期、随机对照试验的最终结果

The Lancet Global Health

IF0

2025-09-170

PREAI

Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine

少即是多吗？在评估RTS,S/AS01E疟疾疫苗的接种效果时，如何考虑分次剂量接种方案及不同剂次的疫苗接种数量

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2024-03-040

OAAI

Efficacy of a bivalent (D614+B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

LANCET RESPIRATORY MEDICINE

IF32.8

2023-11-019

OAAI

Dayan, Gustavo H.; Rouphael, Nadine; Walsh, Stephen R.; Chen, Aiying; Grunenberg, Nicole; Allen, Mary; Antony, Johannes; Asante, Kwaku Poku; Bhate, Amit Suresh; Beresnev, Tatiana; Bonaparte, Matthew, I; Celle, Mederic; Ceregido, Maria Angeles; Corey, Lawrence; Dobrianskyi, Dmytro; Fu, Bo; Grillet, Marie-Helene; Keshtkar-Jahromi, Maryam; Juraska, Michal; Kee, Jiajin; Kibuuka, Hannah; Koutsoukos, Marguerite; Masotti, Roger; Michael, Nelson L.; Neuzil, Kathleen M.; Reynales, Humberto; Robb, Merlin L.; Martinez, Sandra M. Villagomez; Sawe, Fredrick; Schuerman, Lode; Tong, Tina; Treanor, John; Wartel, Tanh; Diazgranados, Carlos A.; Chicz, Roman M.; Gurunathan, Sanjay; Sridhar, Saranya; Savarino, Stephen

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

ECLINICALMEDICINE

IF10

2023-10-013

OAAI

Dayan, Gustavo H.; Rouphael, Nadine; Walsh, Stephen R.; Chen, Aiying; Grunenberg, Nicole; Allen, Mary; Antony, Johannes; Bhate, Amit Suresh; Beresnev, Tatiana; Bonaparte, Matthew I.; Celle, Mederic; Ceregido, Maria Angeles; Corey, Lawrence; Fu, Bo; Grillet, Marie-Helene; Keshtkar-Jahromi, Maryam; Juraska, Michal; Kee, Jia Jin; Kaali, Seyram; Koutsoukos, Marguerite; Masotti, Roger; Michael, Nelson L.; Neuzil, Kathleen M.; Reynales, Humberto; Robb, Merlin L.; Uchiyama, Akiyoshi; Sawe, Fredrick; Schuerman, Lode; Shrestha, Rajeev; Tong, Tina; Treanor, John; Diazgranados, Carlos A.; Chicz, Roman M.; Gurunathan, Sanjay; Savarino, Stephen; Sridhar, Saranya

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

带有AS03佐剂的变体适应SARS-CoV-2重组蛋白疫苗作为授权疫苗的成人助推器的安全性和免疫原性: 一项3期平行组研究

ECLINICALMEDICINE

IF10

2023-08-018

OAAI

de Bruyn, Guy; Wang, Joyce; Purvis, Annie; Ruiz, Martin Sanchez; Adhikarla, Haritha; Alvi, Saad; Bonaparte, Matthew I.; Brune, Daniel; Bueso, Agustin; Canter, Richard M.; Ceregido, Maria Angeles; Deshmukh, Sachin; Diemert, David; Finn, Adam; Forrat, Remi; Fu, Bo; Gallais, Julie; Griffin, Paul; Grillet, Marie-Helene; Haney, Owen; Henderson, Jeffrey A.; Koutsoukos, Marguerite; Launay, Odile; Torres, Federico Martinon; Masotti, Roger; Michael, Nelson L.; Park, Juliana; Rivera-Medina, Doris Maribel; Romanyak, Natalya; Rook, Chris; Schuerman, Lode; Sher, Lawrence D.; Tavares-Da-Silva, Fernanda; Whittington, Ashley; Chicz, Roman M.; Gurunathan, Sanjay; Savarino, Stephen; Sridhar, Saranya

Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2022-12-121

OAAI

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

LANCET INFECTIOUS DISEASES

IF31

2022-09-0123

OAAI

Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2 randomised, dose-finding, multicentre study

LANCET INFECTIOUS DISEASES

IF31

2022-05-0143

OAAI

Sridhar, Saranya; Joaquin, Arnel; Bonaparte, Matthew, I; Bueso, Agustin; Chabanon, Anne-Laure; Chen, Aiying; Chicz, Roman M.; Diemert, David; Essink, Brandon J.; Fu, Bo; Grunenberg, Nicole A.; Janosczyk, Helene; Keefer, Michael C.; Rivera, Doris M. M.; Meng, Ya; Michael, Nelson L.; Munsiff, Sonal S.; Ogbuagu, Onyema; Raabe, Vanessa N.; Severance, Randall; Rivas, Enrique; Romanyak, Natalya; Rouphael, Nadine G.; Schuerman, Lode; Sher, Lawrence D.; Walsh, Stephen R.; White, Judith; von Barbier, Dalia; de Bruyn, Guy; Canter, Richard; Grillet, Marie-Helene; Keshtkar-Jahromi, Maryam; Koutsoukos, Marguerite; Lopez, Denise; Masotti, Roger; Mendoza, Sandra; Moreau, Catherine; Ceregido, Maria Angeles; Ramirez, Shelly; Said, Ansoyta; Tavares-Da-Silva, Fernanda; Shi, Jiayuan; Tong, Tina; Treanor, John; Diazgranados, Carlos A.; Savarino, Stephen

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2 dose-ranging study ,

LANCET INFECTIOUS DISEASES

IF31

2021-09-0186

OAAI

Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials

根据2 1时间表在南非儿童中使用肺炎球菌结合疫苗预防接种婴儿后的细菌性鼻咽运输: 两项临床试验的探索性分析

EXPERT REVIEW OF VACCINES

IF4.8

2020-12-213

OAAI

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2020-01-175

OAAI

RTS,S malaria vaccine could provide major public health benefits

LANCET

IF88.5

2019-08-0119

PREAI

Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial

LANCET INFECTIOUS DISEASES

IF31

2019-08-0142

PREAI

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2019-04-2343

OAAI

Mendoza, Yolanda Guerra; Garric, Elodie; Leach, Amanda; Lievens, Marc; Ofori-Anyinam, Opokua; Pircon, Jean-Yves; Stegmann, Jens-Ulrich; Vandoolaeghe, Pascale; Otieno, Lucas; Otieno, Walter; Owusu-Agyei, Seth; Sacarlal, Jahit; Masoud, Nahya Salim; Sorgho, Hermann; Tanner, Marcel; Tinto, Halidou; Valea, Innocent; Mtoro, Ali Takadir; Njuguna, Patricia; Oneko, Martina; Otieno, Godfrey Allan; Otieno, Kephas; Gesase, Samwel; Hamel, Mary J.; Hoffman, Irving; Kaali, Seyram; Kamthunzi, Portia; Kremsner, Peter; Lanaspa, Miguel; Lell, Bertrand; Lusingu, John; Malabeja, Anangisye; Aide, Pedro; Akoo, Pauline; Ansong, Daniel; Asante, Kwaku Poku; Berkley, James A.; Adjei, Samuel; Agbenyega, Tsiri; Agnandji, Selidji Todagbe; Schuerman, Lode

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2018-04-1312

OAAI

Valea, Innocent; Adjei, Samuel; Usuf, Effua; Traore, Ousmane; Ansong, Daniel; Tinto, Halidou; Boateng, Harry Owusu; Leach, Amanda; Some, Athanase Mwinessobaonfou; Buabeng, Patrick; Vekemans, Johan; Nana, Louis Arnaud; Kotey, Amos; Vandoolaeghe, Pascale; Ouedraogo, Florence; Sambian, David; Lievens, Marc; Tahita, Marc Christian; Rettig, Theresa; Jongert, Erik; Lompo, Palpouguini; Idriss, Ali; Borys, Dorota; Ouedraogo, Sayouba; Prempeh, Frank; Habib, Md Ahsan; Schuerman, Lode; Sorgho, Hermann; Agbenyega, Tsiri

Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial

EXPERT REVIEW OF VACCINES

IF4.8

2017-05-159

OAAI

Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial

10价肺炎球菌非典型流感嗜血杆菌蛋白D结合疫苗对巴拿马儿童急性中耳炎和鼻咽携带的疗效-一项随机对照试验

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2017-04-0324

OAAI

The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination